Agent Orange Exposure Tied to Bladder Cancer Risk in Veterans

[MEDPAGE TODAY]( Oncology Update Tuesday, June 27, 2023 [Agent Orange Exposure Tied to Bladder Cancer Risk in Veterans]( [PET-CT Superior to Conventional Scans for Spotting Distant Breast Cancer Mets]( [Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?]( [The Global Challenges of Psycho-Oncology]( ADVERTISEMENT Exclusives & Features [When Wegovy Doesn't Work for Weight Loss]( [Penn Medicine Pulls Out of U.S. News Hospital Rankings]( [At $20K, Stem Cell Eye Injections May Also Cost Patients Their Sight]( [Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up]( Purpose: To investigate whether circulating-tumor DNA (ctDNA) assessment in patients with muscle-invasive bladder cancer predicts treatment response and provides early detection of metastatic... [READ MORE]( [Sarah, the Duchess of York, undergoes surgery following breast cancer diagnosis]( The 63-year-old was diagnosed with early-stage breast cancer following a routine mammogram. The surgery was a success and Sarah's prognosis is good, the duchess's spokesperson said. [READ MORE]( ['ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.]( Management of classical Hodgkin lymphoma in older patients is challenging due to poor tolerance of the chemotherapy regimens used in younger patients. We modified the BEACOPP regimen (bleomycin,... [READ MORE]( [ERBB4 Mutant Alleles Found in BRAF WT Melanomas That Drive the Proliferation of a BRAF WT Melanoma Cell Line]( Metastatic skin cutaneous melanomas that contain wild-type BRAF alleles ("BRAF WT melanomas") remain a significant clinical challenge, primarily because of the paucity of targets for therapeutic... [READ MORE]( [How the Shortage of a $15 Cancer Drug Is Upending Treatment]( Older generic chemotherapy drugs remain scarce, forcing doctors to put a priority on the patients who have the best chance of survival. [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-06-27&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011